MYASTHENIA GRAVIS (MG)

Clinical trials for MYASTHENIA GRAVIS (MG) explained in plain language.

Never miss a new study

Get alerted when new MYASTHENIA GRAVIS (MG) trials appear

Sign up with your email to follow new studies for MYASTHENIA GRAVIS (MG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 1

New drug trial offers hope for debilitating muscle disease

Disease control Not yet recruiting

This early-stage clinical trial is testing whether an experimental drug called ripertamab is safe and effective for treating generalized myasthenia gravis, a chronic autoimmune disease that causes muscle weakness. The study will involve 20 adults who will receive either ripertama…

Matched conditions: MYASTHENIA GRAVIS (MG)

Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

MYASTHENIA GRAVIS (MG)

Get alerted when new MYASTHENIA GRAVIS (MG) trials appear

New drug trial offers hope for debilitating muscle disease